Functional correlates of repeated administration of cocaine and apomorphine in the rat. 1995

F E Pontieri, and C Mainero, and M La Riccia, and F Passarelli, and F Orzi
Dipartimento di Scienze Neurologiche, Università La Sapienza, Rome, Italy.

The [14C]2-deoxyglucose method was applied to measure the effects of repeated (8 consecutive days) administration of apomorphine (0.5 mg/kg/day s.c.) or cocaine (15 mg/kg/day i.p.) on cerebral glucose utilization in freely moving rats. Altered rates of glucose utilization were measured in extrapyramidal motor areas, such as the globus pallidus, entopeduncular nucleus, subthalamic nucleus, substantia nigra and lateral habenula of both cocaine- and apomorphine-treated rats. Furthermore, cocaine-treated animals displayed increased glucose metabolism in the mesolimbic dopaminergic projections, such as nucleus accumbens and olfactory tubercle, and in the hippocampus. These results suggest that altered functional activity within the dopaminergic mesolimbic system may play a role in the process of sensitization to psychomotor stimulant drugs.

UI MeSH Term Description Entries
D008297 Male Males
D009043 Motor Activity Body movements of a human or an animal as a behavioral phenomenon. Activities, Motor,Activity, Motor,Motor Activities
D009294 Narcotics Agents that induce NARCOSIS. Narcotics include agents that cause somnolence or induced sleep (STUPOR); natural or synthetic derivatives of OPIUM or MORPHINE or any substance that has such effects. They are potent inducers of ANALGESIA and OPIOID-RELATED DISORDERS. Analgesics, Narcotic,Narcotic Analgesics,Narcotic,Narcotic Effect,Narcotic Effects,Effect, Narcotic,Effects, Narcotic
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D001923 Brain Chemistry Changes in the amounts of various chemicals (neurotransmitters, receptors, enzymes, and other metabolites) specific to the area of the central nervous system contained within the head. These are monitored over time, during sensory stimulation, or under different disease states. Chemistry, Brain,Brain Chemistries,Chemistries, Brain
D003042 Cocaine An alkaloid ester extracted from the leaves of plants including coca. It is a local anesthetic and vasoconstrictor and is clinically used for that purpose, particularly in the eye, ear, nose, and throat. It also has powerful central nervous system effects similar to the amphetamines and is a drug of abuse. Cocaine, like amphetamines, acts by multiple mechanisms on brain catecholaminergic neurons; the mechanism of its reinforcing effects is thought to involve inhibition of dopamine uptake. Cocaine HCl,Cocaine Hydrochloride,HCl, Cocaine,Hydrochloride, Cocaine
D003847 Deoxyglucose 2-Deoxy-D-arabino-hexose. An antimetabolite of glucose with antiviral activity. 2-Deoxy-D-glucose,2-Deoxyglucose,2-Desoxy-D-glucose,2 Deoxy D glucose,2 Deoxyglucose,2 Desoxy D glucose
D004734 Energy Metabolism The chemical reactions involved in the production and utilization of various forms of energy in cells. Bioenergetics,Energy Expenditure,Bioenergetic,Energy Expenditures,Energy Metabolisms,Expenditure, Energy,Expenditures, Energy,Metabolism, Energy,Metabolisms, Energy
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001058 Apomorphine A derivative of morphine that is a dopamine D2 agonist. It is a powerful emetic and has been used for that effect in acute poisoning. It has also been used in the diagnosis and treatment of parkinsonism, but its adverse effects limit its use. Apokinon,Apomorphin-Teclapharm,Apomorphine Chloride,Apomorphine Hydrochloride,Apomorphine Hydrochloride Anhydrous,Apomorphine Hydrochloride, Anhydrous,Apomorphine Hydrochloride, Hemihydrate,Britaject,Apomorphin Teclapharm

Related Publications

F E Pontieri, and C Mainero, and M La Riccia, and F Passarelli, and F Orzi
January 1978, Advances in biochemical psychopharmacology,
F E Pontieri, and C Mainero, and M La Riccia, and F Passarelli, and F Orzi
July 2006, The Journal of neuroscience : the official journal of the Society for Neuroscience,
F E Pontieri, and C Mainero, and M La Riccia, and F Passarelli, and F Orzi
September 1994, Pharmacology, biochemistry, and behavior,
F E Pontieri, and C Mainero, and M La Riccia, and F Passarelli, and F Orzi
February 2010, Psychopharmacology,
F E Pontieri, and C Mainero, and M La Riccia, and F Passarelli, and F Orzi
May 1986, Neuroscience research,
F E Pontieri, and C Mainero, and M La Riccia, and F Passarelli, and F Orzi
January 1989, Journal of neural transmission. Parkinson's disease and dementia section,
F E Pontieri, and C Mainero, and M La Riccia, and F Passarelli, and F Orzi
December 2009, Psychopharmacology,
F E Pontieri, and C Mainero, and M La Riccia, and F Passarelli, and F Orzi
June 1991, Clinical neuropharmacology,
F E Pontieri, and C Mainero, and M La Riccia, and F Passarelli, and F Orzi
January 1996, Polish journal of pharmacology,
F E Pontieri, and C Mainero, and M La Riccia, and F Passarelli, and F Orzi
January 1993, Journal of the neurological sciences,
Copied contents to your clipboard!